Bernzott Capital Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Buy
76,376
+8,099
+12% +$552K 2.39% 16
2026
Q1
$4.41M Buy
68,277
+483
+0.7% +$34K 2.11% 30
2025
Q4
$4.56M Sell
67,794
-1,458
-2% -$98.1K 2.17% 27
2025
Q3
$5.08M Sell
69,252
-1,151
-2% -$76.5K 2.4% 25
2025
Q2
$3.66M Sell
70,403
-31,357
-31% -$1.78M 1.87% 30
2025
Q1
$6.49M Buy
101,760
+7,775
+8% +$452K 3.2% 13
2024
Q4
$4.49M Buy
+93,985
New +$4.82M 2.22% 28
2024
Q3
Sell
-187,249
Closed -$9.8M 36
2024
Q2
$9.8M Sell
187,249
-22,555
-11% -$989K 4.52% 1
2024
Q1
$8.53M Buy
209,804
+84,825
+68% +$3.18M 3.38% 9
2023
Q4
$4.62M Sell
124,979
-46,829
-27% -$1.76M 1.8% 35
2023
Q3
$6.56M Sell
171,808
-132,201
-43% -$5.42M 2.26% 25
2023
Q2
$11M Sell
304,009
-17,406
-5% -$594K 2.37% 20
2023
Q1
$12.3M Sell
321,415
-123,313
-28% -$5.78M 2.54% 13
2022
Q4
$25.3M Sell
444,728
-10,855
-2% -$556K 3.27% 7
2022
Q3
$18M Buy
455,583
+82,765
+22% +$3.66M 2.48% 18
2022
Q2
$16.4M Buy
372,818
+116,633
+46% +$5.04M 1.81% 27
2022
Q1
$10.2M Buy
+256,185
New +$9.13M 0.94% 37

Other funds holding HALO

Bernzott Capital Advisors's HALO Position: Q2 2026 in Review

Bernzott Capital Advisors increased its Halozyme (HALO) stake by 12% in Q2 2026, buying an estimated $552K and bringing the position to 76,376 shares worth $5.98M. The position accounts for 2.39% of the portfolio, ranked #16.

Bernzott Capital Advisors first reported a position in HALO in Q1 2022 and has held it in 17 quarters since. The position peaked at $25.3M in Q4 2022. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bernzott Capital Advisors held 76,376 shares of Halozyme worth $5.98M as of Q2 2026.
  • Bernzott Capital Advisors bought 8,099 Halozyme shares in Q2 2026, an estimated $552K.
  • Halozyme made up 2.39% of Bernzott Capital Advisors's portfolio in Q2 2026, its #16 holding.
  • Bernzott Capital Advisors first reported a position in Halozyme in Q1 2022 and has held it in 17 quarters since.
  • Bernzott Capital Advisors's Halozyme position peaked at $25.3M in Q4 2022.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bernzott Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.